首页> 外文期刊>Clinical nuclear medicine >Evaluation of Oxalate Osteopathy Secondary to Hyperoxaluria With 18F-FDG PET/CT and 99mTc-HMDP Bone Scan
【24h】

Evaluation of Oxalate Osteopathy Secondary to Hyperoxaluria With 18F-FDG PET/CT and 99mTc-HMDP Bone Scan

机译:用18F-FDG PET / CT和99MTC-HMDP骨扫描评价二次高血症骨疗养疗法次级患者

获取原文
获取原文并翻译 | 示例
           

摘要

We report a case of a 69-year-old woman with primary hyperoxaluria type I, who developed a severe hypercalcemia despite controlled secondary hyperparathyroidism. Bone scintigraphy showed diffuse increased uptake in axial and peripheral skeleton. F-18-FDG PET/CT showed countless striking hypermetabolic foci, interesting 2 types of lesions (joint calcifications and periosteal resorptions). Bone biopsy demonstrated inflammatory changes around many calcium oxalate crystals; hypercalcemia was then related to oxalate osteopathy. Immunotherapy with denosumab was thus initiated. Eighteen months later, a second PET/CT showed decreased F-18-FDG uptake, reflecting treatment efficacy on inflammatory reaction secondary to calcium oxalosis skeletal deposits.
机译:我们举报了一个69岁女性的患有原发性高血糖尿素的女性,尽管受到控制的继发性甲状旁腺功能亢进,但仍然发育了严重的高钙血症。 骨闪烁图显示延伸的轴向和周边骨骼上的增加。 F-18-FDG PET / CT显示无数醒目的超代谢物灶,有趣的2种类型的病变(联合钙化和骨膜复苏)。 骨骼活组织检查显示出围绕许多草酸钙晶体的炎症变化; 高钙血症与草酸盐骨质病变有关。 因此启动了具有Denosumab的免疫疗法。 十八个月后,第二个PET / CT表现出降低的F-18-FDG吸收,反映了次级炎症反应对草药骨骼沉积物的炎症反应的治疗疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号